Amar Khatri Articles

Jul 23, 2020 by Amar Khatri

Is CRISPR Therapeutics Stock a Buy?

The gene-editing pioneer is a favorite among biotech investors and its stock is hitting new highs.

Jul 14, 2020 by Amar Khatri

2 Top Cancer Treatment Stocks To Watch In July

These hidden gems have the potential to deliver significant returns to their shareholders over the long run.

Jul 6, 2020 by Amar Khatri

These 2 Pharma Stocks Could Be Top Stocks in 2020

These pharma stocks are undervalued, and could be solid picks over the long term.

Jul 3, 2020 by Amar Khatri

Is Dynavax Technologies Stock a Buy?

This stock has the potential to break new highs with its key hepatitis B vaccine and emerging vaccine-adjuvant platform for COVID-19 vaccines.

Jun 30, 2020 by Amar Khatri

2 Biotech Stocks That Could Soar in 2020

These companies offer promising pipelines that could deliver in the long term.

Jun 23, 2020 by Amar Khatri

Better Buy: Illumina vs. Guardant Health

Which stock wins in a matchup between these two healthcare stocks?

Jun 15, 2020 by Amar Khatri

2 Top Cancer Treatment Stocks to Buy in June

If you have cash to spare, these cancer stocks are set to soar.

Jun 10, 2020 by Amar Khatri

3 Drug Stocks That Could Soar in 2020

Have extra cash to spare? These drug stocks are significantly undervalued and could make you wealthy in the long run.

Jun 9, 2020 by Amar Khatri

Is Aurinia Pharmaceuticals Stock a Buy?

This biopharma’s drug could be a home run for investors.

Jun 2, 2020 by Amar Khatri

Better Buy: CRISPR Therapeutics vs. Intellia

Which gene editing stock wins this matchup?

Jun 1, 2020 by Amar Khatri

Is Acadia Pharmaceuticals a Buy?

A strong Q1 performance set the tone, but commitment to its strategy will be key to drive the stock higher.

May 18, 2020 by Amar Khatri

Is Amarin Stock a Buy?

Record revenues, international growth, and a potential legal strategy may provide upside.

May 12, 2020 by Amar Khatri

Is Exact Sciences Stock a Buy?

Q1 results were mixed, but the company’s strategy may be key for top-line growth ahead.

Apr 28, 2020 by Amar Khatri

Is Catalyst Pharmaceuticals a Buy?

Several catalysts could drive this biopharma higher, but there are some significant risks ahead, too.

Blue poker chips on stock market background

Apr 23, 2020 by Amar Khatri

Your 2 Top Profit Opportunities in 2020

These two underrated biotech stocks have the potential to soar.

financial health stethoscope money cash hundred bills medical healthcare

Apr 16, 2020 by Amar Khatri

Is Exelixis a Buy?

Cheap and ready to outperform, this under-the-radar biotech stock could be a winner.

Apr 7, 2020 by Amar Khatri

Is BioMarin Pharmaceuticals Stock a Buy?

Is this a prime opportunity for investors to buy the gene therapy drugmaker?

bottles of prescription medicine sitting on shelves in cabinet drugs pills

Mar 11, 2020 by Amar Khatri

This 1 Stock Is a Good Buy During the Coronavirus Sell-Off

Acadia Pharmaceuticals' track record of success and strong pipeline offers an attractive long-term opportunity for investors, especially at a depressed price.

Mar 2, 2020 by Amar Khatri

Can Halozyme Therapeutics Continue Its Momentum in 2020?

The biopharma's strategic moves in 2019 may set the company up for long term growth

research scientists drugs pharma biotech

Feb 28, 2020 by Amar Khatri

Here's Why Clovis Oncology Has Upside Potential in 2020

The cancer-drug maker has a novel medicine that may provide growth opportunities in other areas of cancer.

Amar Khatri

Recent Articles by Amar Khatri